Titlebook: Extracellular Vesicles in Cardiovascular and Metabolic Diseases; Junjie Xiao Book 2023 The Editor(s) (if applicable) and The Author(s), un

太空

發(fā)現(xiàn)

Extracellular Vesicles and Obesitynd oncosomes. EVs are now recognized as important tools of cell-to-cell communication, allowing cells to exchange proteins, lipids, and genetic material to participate in physiological and pathological processes. It has been reported that EVs regulate host–pathogen interactions and participate in pa

有權(quán)威

反省

分開(kāi)

Therapeutics of Extracellular Vesicles in Cardiocerebrovascular and Metabolic Diseasescommunications. EVs are increasingly being recognized as the promising therapeutic agents for many diseases, including cardiocerebrovascular and metabolic diseases, due to their ability to deliver functional and therapeutical molecules. In this chapter, the biological characteristics and functions o

inspiration

Gene Therapy of Extracellular Vesicles in Cardiovascular and Metabolic Diseaseshe cellular plasma membrane entry-system, then escaping degradation in the cytosol and in most cases, we need an efficient hacking of the nuclear membrane-system, achieving the delivery of genetic construct into the central stage of the target cells: nucleoplasm or chromosomal DNA found in this high

紡織品

Extracellular Vesicles and Cardiac Agingar calcification, among others. The molecular signature of these EVs is highly variable and might provide important information for the development of aging-related biomarkers. Conversely, EVs released by the stem and progenitor cells can exert a rejuvenating effect, raising the possibility of futur

CAGE

Ondines-curse

Extracellular Vesicles and Hypertensionxtracellular vesicles have been proved to have the potential to be served as new biomarkers in the diagnosis, treatment, and prognosis assessment of hypertension. In the future, large multicenter cohorts are highly in demand for further verifying the sensitivity and specificity of extracellular vesi

venous-leak